Jabil healthcare signs strategic collaboration agreement with e3d, expanding pharmaceutical market offering

St. petersburg, fla.--(business wire)--jabil healthcare, a division of jabil inc. (nyse: jbl), today announced it has entered a strategic collaboration agreement with global drug delivery device company e3d, a member of the elcam medical group, which gives jabil access to e3d's reusable mechanical auto-injector. under the terms of this deal, jabil has secured exclusive rights to develop a high-volume reusable auto-injector and connected variants. the agreement enables jabil healthcare to furthe
JBL Ratings Summary
JBL Quant Ranking